Aurora Cannabis (TSE:ACB) Trading 20.8% Higher – Still a Buy?

Aurora Cannabis Inc. (TSE:ACB)’s share price traded up 20.8% during trading on Tuesday . The company traded as high as C$4.91 and last traded at C$4.87. 1,683,109 shares traded hands during mid-day trading, an increase of 311% from the average session volume of 409,698 shares. The stock had previously closed at C$4.03.

Analyst Ratings Changes

Several brokerages have issued reports on ACB. Canaccord Genuity Group cut their target price on shares of Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating on the stock in a research note on Tuesday, June 30th. BMO Capital Markets upgraded Aurora Cannabis to a “hold” rating in a report on Wednesday, August 5th. Finally, TD reduced their price objective on Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating for the company in a research note on Friday, June 12th. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of C$7.17.

Aurora Cannabis Trading Up 5.2%

The company has a debt-to-equity ratio of 4.30, a current ratio of 5.36 and a quick ratio of 2.48. The company has a fifty day moving average of C$4.08 and a 200-day moving average of C$4.60. The firm has a market capitalization of C$327.67 million, a PE ratio of -2.73 and a beta of 0.25.

Aurora Cannabis (TSE:ACB) last issued its earnings results on Wednesday, August 5th. The company reported C($0.07) EPS for the quarter. Aurora Cannabis had a negative net margin of 9.53% and a negative return on equity of 5.21%. The firm had revenue of C$67.55 million during the quarter. On average, sell-side analysts anticipate that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.